A Study of Aztreonam-Avibactam (ATM-AVI) Compared to Best Available Therapy in Pediatric Participants with Serious Gram-Negative Bacterial Complicated Intra-abdominal, Complicated Urinary Tract, Blood Stream Infections, and Hospital Acquired and Ventilator Associated Pneumonia

Authors
Category Primary study
Registry of TrialsClinical Trials Information System
Year 2022
This article has no abstract
Epistemonikos ID: 13ff51da4d43e6c6269ca863af9a8e8ff023ae0c
First added on: Mar 21, 2025